Stock Analiz

MMM vs MDLN stock comparison

3M vs. Medline · data as of November 13, 2026

3M (MMM) has a market value of about $94.9B, Medline (MDLN) about $51.9B. Over their latest twelve months 3M had revenue of $25.2B and Medline $30.7B.

On our five checks 3M scores higher: 1.4 out of 5 (weak) against 1.0 (weak).

By area, the stronger company is Medline on future growth; 3M on track record; Medline on financial health; 3M on shareholder returns.

3M is cheaper on earnings (P/E 27.4 vs. 89.7).

3M leads on 12 of the compared lines and Medline on 9.

Side by side

MMMMDLN
Size and price
Market cap$94.9B$51.9B
Share price$183.66$39.47
Score
Overall score (of 5)1.41.0
Value00
Future growth12
Track record10
Financial health12
Shareholder returns41
Valuation
P/E (TTM)27.489.7
Forward P/E19.826.2
Price / free cash flow35.527.4
Price / sales3.81.7
EV / EBITDA17.122.6
PEG——
DCF value vs. price−52%−48%
Business
Revenue$25.2B$30.7B
Net income$3.5B$566M
Free cash flow$2.7B$1.9B
Net margin14.0%1.8%
Gross margin (5-yr avg.)41.3%26.4%
ROIC (5-yr avg.)6.8%8.6%
Growth
Revenue growth (1 yr)1.5%11.5%
Revenue growth (5 yrs, per year)-5.0%—
EPS growth (5 yrs, per year)-8.5%—
Balance sheet and payouts
Net cash (cash minus debt)-$10.8B-$9.1B
Dividend yield1.70%None
Shareholder yield5.1%0.1%
Analysts
Upside to average target+5%+15%
Consensus ratingBuyBuy

Highlighted = the better figure on that line. Revenue, net income and free cash flow: MMM TTM to September 30, 2026, MDLN TTM to September 30, 2026. Not investment advice.

Frequently asked questions

Which is the better stock, 3M or Medline?

We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) 3M scores 1.4 out of 5 and Medline 1.0; the table shows where each one is stronger.

Is 3M cheaper than Medline?

On trailing earnings, 3M trades at a P/E of 27.4 and Medline at 89.7, so 3M is cheaper by this measure. A lower P/E can also reflect slower expected growth.

Which pays a higher dividend?

3M yields 1.70% and Medline nothing (no dividend).

Full 3M analysis → Full Medline analysis →

More comparisons

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.